KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Shares Issued (2019 - 2025)

Hims & Hers Health's Shares Issued history spans 6 years, with the latest figure at $8.1 million for Q4 2025.

  • For Q4 2025, Shares Issued fell 67.79% year-over-year to $8.1 million; the TTM value through Dec 2025 reached $11.0 million, down 58.6%, while the annual FY2025 figure was $11.0 million, 58.6% down from the prior year.
  • Shares Issued for Q4 2025 was $8.1 million at Hims & Hers Health, up from -$958000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $25.0 million in Q4 2024 and bottomed at -$14.8 million in Q3 2024.
  • The 5-year median for Shares Issued is $607000.0 (2023), against an average of $2.1 million.
  • The largest YoY upside for Shares Issued was 4023.39% in 2024 against a maximum downside of 1413.0% in 2024.
  • A 5-year view of Shares Issued shows it stood at -$787000.0 in 2021, then tumbled by 174.08% to -$2.2 million in 2022, then soared by 128.14% to $607000.0 in 2023, then soared by 4023.39% to $25.0 million in 2024, then crashed by 67.79% to $8.1 million in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Shares Issued are $8.1 million (Q4 2025), -$958000.0 (Q2 2025), and $3.9 million (Q1 2025).